In today’s edition of Small Cap News Movers, we spotlight some of the most active and news-driven small-cap stocks. From…
Read More »Biotech
Biotech can be brutal, but when a tiny stock with a tight float and a powerful narrative starts to run,…
Read More »Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) is doubling down on two fronts—market advocacy and product expansion. This week,…
Read More »Shuttle Pharmaceuticals (NASDAQ: SHPH) is advancing its mission to revolutionize prostate cancer treatment. On April 10, 2025, the company announced…
Read More »The broader market experienced mixed performance to start the week, with major indices continuing to display volatility. On Monday, Dow…
Read More »Summary First-Mover Advantage: Soleno has the market to itself until competition intensifies. High Sales Potential: Projected sales of $876 million…
Read More »Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) is making headlines in April, launching its innovative alcohol detox drink, unbuzzd™,…
Read More »As President Trump’s sweeping tariffs and immigration policies continue to weigh on financial markets, many investors have taken a step…
Read More »Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) is riding a wave of optimism following robust financial improvements, promising clinical…
Read More »Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (Upstream: QNTM) isn’t standing still. The biopharmaceutical innovator behind the clinically validated…
Read More »









